Coriolis Pharma is a globally active, science driven contract research and development organization (CRDO) and a premier partner for drug product development, analytical services, and manufacturing across a broad range of biological therapeutic modalities. With deep expertise in both liquid and lyophilized drug products, Coriolis’ scientists design and execute platform and customized services that accelerate and de risk client programs from the very beginning and throughout the entire product lifecycle.

Coriolis Pharma distinguishes itself through scientific excellence, innovative analytical approaches, and a profound understanding of formulation and drug product development. The company is headquartered in Martinsried, Germany, and operates a U.S. facility in the Research Triangle of North Carolina.